Evidence-based treatments and biosimilars are giving health equity a massive boost

With 2023 well underway, health care payers and providers are growing more focused on ensuring equity in patient care. Unfortunately, systemic inequities are complex roadblocks for many who need care and critical services. The National Library of Medicine credits several structural factors, including economic, environmental, social, and fundamental disparities, that can negatively affect access to health care, living conditions, and overall health.

Besides the impact on health outcomes, inequities cause massive inefficiencies and are costly. A nine-year analysis by the Urban Institute found that racial disparities cost health insurance companies about $337 billion. As the health inequity problem has been well-documented in the literature for decades, and multiple root causes have been identified, we are at a critical point in health care where we must consider these issues as we develop new health care technologies.